Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Genes|September 28, 2021
Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics AnalysisJingwen Zou, Kunpeng Du, Shaohua Li, et al.
Frontiers in Medicine|August 30, 2021
Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 RegulatorsJian Zhang, Huali Jiang, Kunpeng Du, et al.
BMC Gastroenterology|July 2, 2025
Primary liver cancer disease burden in Cambodia during 1990-2021: a systematic analysis of datasets from the global burden of disease study 2021Duanyu Wang, Syphanna Sou, Sophearin Rith, et al.
Scientific Reports|March 31, 2024
A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCCChangqian Wang, Xiang Liu, Pengkhun Nov, et al.
Frontiers in Genetics|April 1, 2022
A Multi-Omics Pan-Cancer Analysis of 4EBP1 in Cancer Prognosis and Cancer-Associated Fibroblasts InfiltrationKunpeng Du, Jingwen Zou, Chunshan Liu, et al.
Journal of Pineal Research|July 21, 2021
Pan-cancer analyses reveal genomics and clinical characteristics of the melatonergic regulators in cancerJian Zhang, Huali Jiang, Kunpeng Du, et al.
Frontiers in Immunology|July 18, 2022
A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell CarcinomaKunpeng Du, Jingwen Zou, Baiyao Wang, et al.
Polymers|May 14, 2022
Diblock Copolymers Containing Titanium-Hybridized Polyhedral Oligomeric Silsesquioxane Used as a Macromolecular Flame Retardant for Epoxy ResinRuirui Zhou, Lijie Lin, Birong Zeng, et al.
American Journal of Translational Research|September 10, 2019
Babaodan inhibits cell growth by inducing autophagy through the PI3K/AKT/mTOR pathway and enhances antitumor effects of cisplatin in NSCLC cellsQi Wang, Zhile Liu, Kunpeng Du, et al.
Frontiers in Immunology|March 23, 2023
PD-L1 expression as biomarker of efficacy of PD-1/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysisMuhammad Khan, Kunpeng Du, Meiling Ai, et al.
Pageof 4